Published on: March 07, 2018 at 12:00PM
Condition: Stage IV Prostate Adenocarcinoma AJCC v7
Interventions: Drug: Antiandrogen Therapy; Drug: Docetaxel; Other: Laboratory Biomarker Analysis; Procedure: Quality-of-Life Assessment; Other: Questionnaire Administration; Procedure: Radical Prostatectomy
Sponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2Fya93Y
No comments:
Post a Comment